• A promising new strategy for monitoring erythropoietic protoporphyria therapy
• Clinically important features of porphyrin and heme metabolism and the porphyrias
• Cutanea Tarda Porphyria
• Development of corticobasal syndrome in a patient with congenital erythropoietic porphyria
• Familial porphyria cutanea tarda in Spain: characterization of eight novel mutations in the UROD gene and haplotype analysis of the common p.G281E mutation
• Heme acts through the Bach1b/Nrf2a-MafK pathway to regulate exocrine peptidase precursor genes in porphyric zebrafish
• Hepatoerythropoietic Porphyria
• Hepatoerythropoietic Porphyria Caused by a Novel Homoallelic Mutation in Uroporphyrinogen Decarboxylase Gene in Egyptian Patients
• Hepatoerythropoietic porphyria due to a novel mutation in the uroporphyrinogen decarboxylase gene
• Liver cirrhosis induced by porphyria cutanea tarda: a case report and review
• Liver transplantation in the management of porphyria
• Oral cholestyramine is not an effective treatment for uncomplicated erythropoietic protoporphyria
• Porphyria Cutanea Tarda
• Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations
• Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias
• The cutaneous porphyrias
• Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs